Igor Tudorache
Overview
Explore the profile of Igor Tudorache including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
2210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyaydin E, Gotschy A, Parianos D, Nagele M, Tudorache I, Flammer A, et al.
Heart Fail Rev
. 2025 Feb;
PMID: 39945978
Tricuspid regurgitation (TR) is a common valvular dysfunction following heart transplantation (HT), with reported prevalence rates ranging from 19 to 84%, primarily depending on the duration of follow-up. Its etiology...
2.
Ntinopoulos V, Rodriguez Cetina Biefer H, Tudorache I, Papadopoulos N, Odavic D, Risteski P, et al.
BMJ Health Care Inform
. 2025 Jan;
32(1.
PMID: 39832824
Objectives: We aimed to evaluate the performance of multiple large language models (LLMs) in data extraction from unstructured and semi-structured electronic health records. Methods: 50 synthetic medical notes in English,...
3.
Horke A, Tudorache I, Laufer G, Andreas M, Pomar J, Pereda D, et al.
Eur J Cardiothorac Surg
. 2024 Mar;
65(4).
PMID: 38532304
Objectives: Decellularized aortic homografts (DAH) were introduced as a new option for aortic valve replacement for young patients. Methods: A prospective, EU-funded, single-arm, multicentre study in 8 centres evaluating non-cryopreserved...
4.
Horke A, Bobylev D, Avsar M, Cvitkovic T, Meyns B, Rega F, et al.
Eur J Cardiothorac Surg
. 2024 Mar;
65(4).
PMID: 38532286
Objectives: Decellularized aortic homografts (DAH) were introduced in 2008 as a further option for paediatric aortic valve replacement (AVR). Methods: Prospective, multicentre follow-up of all paediatric patients receiving DAH for...
5.
Beyond Conventional Operations: Embracing the Era of Contemporary Minimally Invasive Cardiac Surgery
Ilcheva L, Risteski P, Tudorache I, Haussler A, Papadopoulos N, Odavic D, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068262
Over the past two decades, minimally invasive cardiac surgery (MICS) has gained a significant place due to the emergence of innovative tools and improvements in surgical techniques, offering comparable efficacy...
6.
Greite R, Schott S, Wang L, Gohlke L, Kreimann K, Derlin K, et al.
Clin Transl Sci
. 2023 Oct;
16(12):2729-2743.
PMID: 37899696
Free heme is released from hemoproteins during hemolysis or ischemia reperfusion injury and can be pro-inflammatory. Most studies on nephrotoxicity of hemolysis-derived proteins focus on free hemoglobin (fHb) with heme...
7.
Sugimura Y, Bauer S, Immohr M, Mehdiani A, Rellecke P, Tudorache I, et al.
Artif Organs
. 2023 Sep;
47(12):1874-1884.
PMID: 37724611
Background: Large Impella systems (5.0 or 5.5; i.e., Impella 5+) (Abiomed Inc., Danvers, MA, USA) help achieve better clinical outcomes through relevant left ventricular unloading in acute cardiogenic shock (CS)....
8.
Jenkins F, Boettger C, Immohr M, Akhyari P, Aubin H, Tudorache I, et al.
Exp Clin Transplant
. 2023 Sep;
21(8):678-683.
PMID: 37698403
Objectives: Donor hearts frequently originate from donors whose lungs are also recovered for transplant. Synchronous heart and lung procurement is more complex than procurement ofthe heart alone, and the effects...
9.
Oehler D, Bottger C, Immohr M, Bruno R, Haschemi J, Scheiber D, et al.
Life (Basel)
. 2023 Jul;
13(7).
PMID: 37511819
Myat Soe Thet et al. published a letter [...].
10.
Jack T, Carlens J, Diekmann F, Hasan H, Chouvarine P, Schwerk N, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1193326.
PMID: 37441704
Background: Bilateral lung transplantation (LuTx) remains the only established treatment for children with end-stage pulmonary arterial hypertension (PAH). Although PAH is the second most common indication for LuTx, little is...